Skip to main content
. Author manuscript; available in PMC: 2010 Aug 5.
Published in final edited form as: Mol Endocrinol. 2007 May 15;21(8):1861–1876. doi: 10.1210/me.2006-0101

Fig. 4. Localization of GFP, GFP-CTHER4, and GFP-s80HER4 in HC11 cells.

Fig. 4

A, Live cell microscopy showing the localization of GFP fluorescence in HC11 cells stably expressing GFP, GFP-CTHER4, or GFP-s80HER4. Phase contrast is shown in lower panels. Bar, 100 μm, applies to each image. B, HC11 cells stably expressing GFP (a-c, j-l), GFP-CTHER4 (d-f, m-o) or GFP-s80HER4 (g-i, p-r), were treated without (a-i), or with (j-r) 20 ng/ml of leptomycin B for 24 h, then analyzed for GFP fluorescence by confocal microscopy. Subcellular distribution of GFP (a, j), GFP-CT (d, m), GFP-s80 (g, p), and DAPI (b, e, h, k, n, q) were visualized and captured. The merged pictures were also shown (c, f, i, l, o, r). Bar, 30 μm, applies to each image.